Go to
current issue
-
Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study Blood Cancer J. (IF 12.8) Pub Date : 2023-11-27 Miao Wang, Han-Yu Cao, Kai-Wen Tan, Qiao-Cheng Qiu, Yuan-Hong Huang, Shuai-shuai Ge, Zi-Hao Wang, Jia Chen, Xiao-Wen Tang, De-Pei Wu, Sheng-Li Xue, Zheng Li, Hai-Ping Dai
-
Safety and efficacy of teclistamab in systemic immunoglobulin light chain amyloidosis Blood Cancer J. (IF 12.8) Pub Date : 2023-11-27 Rajshekhar Chakraborty, Divaya Bhutani, Mathew S. Maurer, Meera Mohan, Suzanne Lentzsch, Anita D’Souza
-
SRSF2 mutation reduces polycythemia and impairs hematopoietic progenitor functions in JAK2V617F-driven myeloproliferative neoplasm Blood Cancer J. (IF 12.8) Pub Date : 2023-11-27 Yue Yang, Salar Abbas, Mohammad A. Sayem, Avik Dutta, Golam Mohi
-
Outcomes of t(11;14) light chain (AL) amyloidosis after autologous stem cell transplantation: benchmark for new therapies Blood Cancer J. (IF 12.8) Pub Date : 2023-11-15 Susan Bal, Noel Estrada-Merly, Luciano J. Costa, Muzaffar H. Qazilbash, Shaji Kumar, Anita D’Souza
-
Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study Blood Cancer J. (IF 12.8) Pub Date : 2023-11-13 Allison M. Bock, Jennifer J. Gile, Melissa C. Larson, Kittika Poonsombudlert, Reema K. Tawfiq, Seth Maliske, Matthew J. Maurer, Brian F. Kabat, Jonas Paludo, David J. Inwards, Sabarish Ayyappan, Brian K. Link, Stephen M. Ansell, Thomas M. Habermann, Thomas E. Witzig, Grzegorz S. Nowakowski, James R. Cerhan, Umar Farooq, Yucai Wang
-
Risk-directed therapy based on genetics and MRD improves the outcomes of AML1-ETO-positive AML patients, a multi-center prospective cohort study Blood Cancer J. (IF 12.8) Pub Date : 2023-11-13 Dan Xu, Ying Yang, Zhao Yin, Sanfang Tu, Danian Nie, Yiqing Li, Zhenqian Huang, Qixin Sun, Changfen Huang, Xiaqi Nie, Zurong Yao, Pengcheng Shi, Yu Zhang, Xuejie Jiang, Qifa Liu, Guopan Yu
-
Concomitant 1q+ and t(4;14) influences disease characteristics, immune system, and prognosis in double-hit multiple myeloma Blood Cancer J. (IF 12.8) Pub Date : 2023-11-10 Michael Ozga, Qiuhong Zhao, Laila Huric, Cecelia Miller, Ashley Rosko, Abdullah Khan, Elvira Umyarova, Don Benson, Francesca Cottini
-
Minor GPI(-) granulocyte populations in aplastic anemia and healthy individuals derived from a few PIGA-mutated hematopoietic stem progenitor cells Blood Cancer J. (IF 12.8) Pub Date : 2023-11-08 Hiroki Mizumaki, Dung Cao Tran, Kohei Hosokawa, Kazuyoshi Hosomichi, Yoshitaka Zaimoku, Hiroyuki Takamatsu, Hirohito Yamazaki, Ken Ishiyama, Rena Yamazaki, Hiroshi Fujiwara, Atsushi Tajima, Shinji Nakao
-
Donor cell-derived genetic abnormalities after sex mismatched allogeneic cell transplantation: a unique challenge of donor cell leukemia Blood Cancer J. (IF 12.8) Pub Date : 2023-11-06 Melanie Klausner, Brian Phan, Laura Morsberger, Rebecca Parish, Alison Shane, Rebecca Park, Christopher D. Gocke, Rena R. Xian, Rick John Jones, Javier Bolaños-Meade, Lukasz P. Gondek, Michael Phan, Ying S. Zou
-
Cellular aging is accelerated in the malignant clone of myeloproliferative neoplasms Blood Cancer J. (IF 12.8) Pub Date : 2023-11-06 Margherita Vieri, Vithurithra Tharmapalan, Milena Kalmer, Julian Baumeister, Miloš Nikolić, Matthis Schnitker, Martin Kirschner, Niclas Flosdorf, Marcelo A. S. de Toledo, Martin Zenke, Steffen Koschmieder, Tim H. Brümmendorf, Fabian Beier, Wolfgang Wagner
-
Prognostic impact of translocation t(14;16) in multiple myeloma according to the presence of additional genetic lesions Blood Cancer J. (IF 12.8) Pub Date : 2023-10-26 Anaïs Schavgoulidze, Aurore Perrot, Titouan Cazaubiel, Xavier Leleu, Lydia Montes, Caroline Jacquet, Karim Belhadj, Sabine Brechignac, Laurent Frenzel, Thomas Chalopin, Philippe Rey, Jean-Marc Schiano de Collela, Mamoun Dib, Denis Caillot, Margaret Macro, Jean Fontan, Laure Buisson, Luka Pavageau, Murielle Roussel, Salomon Manier, Mohamad Mohty, Ludovic Martinet, Hervé Avet-Loiseau, Jill Corre
-
Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma Blood Cancer J. (IF 12.8) Pub Date : 2023-10-26 Maja Ludvigsen, Amanda Jessica Campbell, Marie Beck Enemark, Trine Engelbrecht Hybel, Marja-Liisa Karjalainen-Lindsberg, Klaus Beiske, Mette Bjerre, Lars Møller Pedersen, Harald Holte, Sirpa Leppä, Judit Meszaros Jørgensen, Bent Honoré
-
Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma Blood Cancer J. (IF 12.8) Pub Date : 2023-10-13 Surbhi Sidana, Hitomi Hosoya, Alexandria Jensen, Lawrence Liu, Anmol Goyal, Vanna Hovanky, Bita Sahaf, Sushma Bharadwaj, Theresa Latchford, Sally Arai, Sheryl Leahy, Matthew Mei, Lihua E. Budde, Lori S. Muffly, Matthew J. Frank, Saurabh Dahiya, Myo Htut, David Miklos, Murali Janakiram
-
Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models Blood Cancer J. (IF 12.8) Pub Date : 2023-10-13 Jelena Jelicic, Karen Juul-Jensen, Zoran Bukumiric, Michael Roost Clausen, Ahmed Ludvigsen Al-Mashhadi, Robert Schou Pedersen, Christian Bjørn Poulsen, Peter Brown, Tarec Christoffer El-Galaly, Thomas Stauffer Larsen
-
Immune-depleted tumor microenvironment is associated with poor outcomes and BTK inhibitor resistance in mantle cell lymphoma Blood Cancer J. (IF 12.8) Pub Date : 2023-10-12 Preetesh Jain, Krystle Nomie, Nikita Kotlov, VitaIy Segodin, Holly Hill, Chi Young Ok, Ahmed Fetooh, Rashmi Kanagal-Shamanna, Francisco Vega, Alexander Bagaev, Nathan Fowler, Christopher R. Flowers, Michael Wang
-
Efficacy of venetoclax combined with hypomethylating agents in young, and unfit patients with newly diagnosed core binding factor acute myeloid leukemia Blood Cancer J. (IF 12.8) Pub Date : 2023-10-11 Keyuan Zhang, Xiang Zhang, Yang Xu, Shengli Xue, Huiying Qiu, Xiaowen Tang, Yue Han, Suning Chen, Aining Sun, Yanming Zhang, Depei Wu, Ying Wang
-
Correction: Zanubrutinib: past, present, and future. Blood Cancer J. (IF 12.8) Pub Date : 2023-10-02 Constantine S Tam,Javier L Muñoz,John F Seymour,Stephen Opat
-
Clinical characteristics and outcomes in risk-stratified patients with smoldering multiple myeloma: data from the Czech Republic Registry of Monoclonal Gammopathies Blood Cancer J. (IF 12.8) Pub Date : 2023-09-27 Viera Sandecka, Tereza Popkova, Martin Stork, Vladimir Maisnar, Jiri Minarik, Alexandra Jungova, Petr Pavlicek, Lukas Stejskal, Lenka Pospisilova, Adriana Heindorfer, Jarmila Obernauerova, Evzen Gregora, Michal Sykora, Jana Ullrychova, Marek Wrobel, Petr Kessler, Tomas Jelinek, Peter Kunovszki, Sacheeta Bathija, Blanca Gros, Sabine Wilbertz, Qian Cai, Annette Lam, Ivan Spicka
-
Late effects in survivors of infant acute lymphoblastic leukaemia—a study of the Australian and New Zealand Children’s Haematology/Oncology Group Blood Cancer J. (IF 12.8) Pub Date : 2023-09-26 Denitza Mironova, Chitra M. Saraswati, Peter Downie, Chow Yee Lai, Eleanor Cook, Vickyanne Carruthers, Perla Moukhaiber, Fiona Molloy, Joshua Serov, Elizabeth McKinnon, Frank Alvaro, Michael Osborn, Tamas Revesz, Tim Prestidge, Siobhan Cross, Caroline M. Bateman, Andrew S. Moore, Seong Lin Khaw, Marion K. Mateos, Rishi S. Kotecha
-
The immunome of mobilized peripheral blood stem cells is predictive of long-term outcomes and therapy-related myeloid neoplasms in patients with multiple myeloma undergoing autologous stem cell transplant Blood Cancer J. (IF 12.8) Pub Date : 2023-09-26 Saurabh Zanwar, Eapen K. Jacob, Carl Greiner, Kevin Pavelko, Michael Strausbauch, Emilie Anderson, Arini Arsana, Megan Weivoda, Mithun Vinod Shah, Taxiarchis Kourelis
-
U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity Blood Cancer J. (IF 12.8) Pub Date : 2023-09-21 Talha Badar, Yenny A. Moreno Vanegas, Ahmad Nanaa, James M. Foran, Aref Al-Kali, Abhishek Mangaonkar, Hemant Murthy, Hassan B. Alkhateeb, David Viswanatha, Rong He, Mithun Shah, Cecilia Arana Yi, Mark R. Litzow, Naseema Gangat, Ayalew Tefferi, Mrinal M. Patnaik
-
Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents Blood Cancer J. (IF 12.8) Pub Date : 2023-09-21 Danielle Hammond, Sanam Loghavi, Sa A. Wang, Marina Y. Konopleva, Tapan M. Kadia, Naval G. Daver, Maro Ohanian, Ghayas C. Issa, Yesid Alvarado, Nicholas J. Short, Koji Sasaki, Naveen Pemmaraju, Guillermo Montalban-Bravo, Curtis A. Lachowiez, Abhishek Maiti, Guillermo Garcia-Manero, Elias J. Jabbour, Gautam Borthakur, Farhad Ravandi, Koichi Takahashi, Sherry R. Pierce, Hagop M. Kantarjian, Courtney
-
In-class transition (iCT) of proteasome inhibitor-based therapy: a community approach to multiple myeloma management Blood Cancer J. (IF 12.8) Pub Date : 2023-09-19 Robert M. Rifkin, Saulius K. Girnius, Stephen J. Noga, Ruemu E. Birhiray, Suman Kambhampati, Sudhir Manda, Roger M. Lyons, Habte A. Yimer, Dasha Cherepanov, Eric Lloyd, Presley Whidden, Joshua Richter
-
Eltrombopag with or without Tacrolimus for relapsed/refractory acquired aplastic anaemia: a prospective randomized trial Blood Cancer J. (IF 12.8) Pub Date : 2023-09-19 Jiang Ji, Ziqi Wan, Jing Ruan, Yuan Yang, Qinglin Hu, Zesong Chen, Chen Yang, Miao Chen, Bing Han
-
Adverse outcomes for chronic myeloid leukemia patients with splenomegaly and low in vivo kinase inhibition on imatinib Blood Cancer J. (IF 12.8) Pub Date : 2023-09-11 Chung H. Kok, Verity A. Saunders, Phuong Dang, Naranie Shanmuganathan, Deborah White, Susan Branford, David Yeung, Timothy P. Hughes
-
Treatment of older adults with FLT3-mutated AML: Emerging paradigms and the role of frontline FLT3 inhibitors Blood Cancer J. (IF 12.8) Pub Date : 2023-09-11 Nicholas J. Short, Daniel Nguyen, Farhad Ravandi
-
Identifying novel mechanisms of biallelic TP53 loss refines poor outcome for patients with multiple myeloma Blood Cancer J. (IF 12.8) Pub Date : 2023-09-11 Enze Liu, Parvathi Sudha, Nathan Becker, Oumaima Jaouadi, Attaya Suvannasankha, Kelvin Lee, Rafat Abonour, Mohammad Abu Zaid, Brian A. Walker
-
Zanubrutinib: past, present, and future Blood Cancer J. (IF 12.8) Pub Date : 2023-09-11 Constantine S. Tam, Javier L. Muñoz, John F. Seymour, Stephen Opat
-
The expanding CML treatment landscape: an introspective commentary. Blood Cancer J. (IF 12.8) Pub Date : 2023-09-13 Jeffrey H Lipton
-
Efficacy and safety of front-line treatment regimens for Waldenstrom macroglobulinaemia: a systematic review and meta-analysis Blood Cancer J. (IF 12.8) Pub Date : 2023-09-07 Wee-Lee Chan, Vanessa Cui Lian Chong, Ian Jun Yan Wee, Li Mei Poon, Esther Hian Lee Chan, Joanne Lee, Yen-Lin Chee, Anand D. Jeyasekharan, Wee-Joo Chng, Miny Samuel, Sanjay de Mel
-
PLK1 as a cooperating partner for BCL2-mediated antiapoptotic program in leukemia Blood Cancer J. (IF 12.8) Pub Date : 2023-09-07 Kinjal Shah, Ahmad Nasimian, Mehreen Ahmed, Lina Al Ashiri, Linn Denison, Wondossen Sime, Katerina Bendak, Iryna Kolosenko, Valentina Siino, Fredrik Levander, Caroline Palm-Apergi, Ramin Massoumi, Richard B. Lock, Julhash U. Kazi
-
Prospective evaluation of genome sequencing to compare conventional cytogenetics in acute myeloid leukemia Blood Cancer J. (IF 12.8) Pub Date : 2023-09-06 Beth A. Pitel, Cinthya Zepeda-Mendoza, Zohar Sachs, Hongwei Tang, Suganti Shivaram, Neeraj Sharma, James B. Smadbeck, Stephanie A. Smoley, Kathryn E. Pearce, Ivy M. Luoma, Joselle Cook, Mark R. Litzow, Nicole L. Hoppman, David Viswanatha, Xinjie Xu, Rhett P. Ketterling, Patricia T. Greipp, Jess F. Peterson, Linda B. Baughn
-
Clinical characteristics, genomic profiling and outcomes of single system multifocal Langerhans cell histiocytosis in adults with bone involvement Blood Cancer J. (IF 12.8) Pub Date : 2023-09-05 Hong-xiao Han, Long Chang, Min Lang, He Lin, Jian Li, Ming-hui Duan, Dao-bin Zhou, Xin-xin Cao
-
Clinical and immunological characteristics of prolonged SARS-CoV-2 Omicron infection in hematologic disease Blood Cancer J. (IF 12.8) Pub Date : 2023-09-05 Daisuke Ikeda, Ami Fukumoto, Yuka Uesugi, Rikako Tabata, Daisuke Miura, Kentaro Narita, Masami Takeuchi, Tomohisa Watari, Yoshihito Otsuka, Kosei Matsue
-
Cell-free DNA chromosome copy number variations predict outcomes in plasma cell myeloma Blood Cancer J. (IF 12.8) Pub Date : 2023-09-05 Wanting Qiang, Lina Jin, Tiancheng Luo, Yanchun Jia, Jing Lu, Jin Liu, Haiyan He, Ziliang Qian, Sridurga Mithraprabhu, Yang Liang, Robert Peter Gale, Xia Tao, Depei Wu, Juan Du
-
Identification of NOTCH-driven matrisome-associated genes as prognostic indicators of multiple myeloma patient survival Blood Cancer J. (IF 12.8) Pub Date : 2023-09-05 Daniela Simone Maichl, Julius Arthur Kirner, Susanne Beck, Wen-Hui Cheng, Melanie Krug, Martin Kuric, Carsten Patrick Ade, Thorsten Bischler, Franz Jakob, Dirk Hose, Anja Seckinger, Regina Ebert, Franziska Jundt
-
Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group database Blood Cancer J. (IF 12.8) Pub Date : 2023-09-05 Julie Côté, Richard LeBlanc, Hira Mian, Michael P. Chu, Arleigh McCurdy, Esther Masih-Khan, Jiandong Su, Victor H. Jimenez-Zepeda, Kevin Song, Martha Louzada, Darrell White, Michael Sebag, Anthony Reiman, Julie Stakiw, Rami Kotb, Debra Bergstrom, Muhammad Aslam, Rayan Kaedbey, Christopher P. Venner, Engin Gul, Donna Reece
-
Gemtuzumab ozogamicin plus standard induction hemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia Blood Cancer J. (IF 12.8) Pub Date : 2023-09-04 Hassan Awada, Mina Abdelmalek, Tara Cronin, Jeffrey Baron, Zakariya Kashour, Farhan Azad, Muhammad Salman Faisal, Mark Faber, Matthew Gravina, Pamela J. Sung, Steven D. Green, Amanda Przespolewski, James E. Thompson, Elizabeth A. Griffiths, Eunice S. Wang
-
Baseline immunophenotypic profile of bone marrow leukemia cells in acute myeloid leukemia with nucleophosmin-1 gene mutation: a EuroFlow study Blood Cancer J. (IF 12.8) Pub Date : 2023-09-04 Sergio Matarraz, Pilar Leoz, Ana Yeguas-Bermejo, Vincent van der Velden, Anne E. Bras, Jose I. Sánchez Gallego, Quentin Lecrevisse, Rosa Ayala-Bueno, Cristina Teodosio, Ignacio Criado, María González-González, Juan Flores-Montero, Alejandro Avendaño, María B. Vidriales, María C. Chillón, Teresa González, Ramón García-Sanz, María I. Prieto Conde, Neus Villamor, Laura Magnano, Enrique Colado, Paula Fernández
-
A population-based study of transformed marginal zone lymphoma: identifying outcome-related characteristics Blood Cancer J. (IF 12.8) Pub Date : 2023-09-01 Johanna A. A. Bult, Francien Huisman, Yujie Zhong, Nick Veltmaat, Joost Kluiver, Sanne H. Tonino, Joost S. P. Vermaat, Martine E. D. Chamuleau, Arjan Diepstra, Anke van den Berg, Wouter J. Plattel, Mirian Brink, Marcel Nijland
-
Favorable outcomes of NPM1mut AML patients are due to transcriptional inactivation of FOXM1, presenting a new target to overcome chemoresistance Blood Cancer J. (IF 12.8) Pub Date : 2023-08-22 I. Khan, A. Kaempf, S. Raghuwanshi, M. Chesnokov, X. Zhang, Z. Wang, A. Domling, J. W. Tyner, C. Camacho, A. L. Gartel
-
Metabolic PET/CT analysis of aggressive Non-Hodgkin lymphoma prior to Axicabtagene Ciloleucel CAR-T infusion: predictors of progressive disease, survival, and toxicity Blood Cancer J. (IF 12.8) Pub Date : 2023-08-18 William G. Breen, Jason R. Young, Matthew A. Hathcock, Roman O. Kowalchuk, Matthew P. Thorpe, Radhika Bansal, Arushi Khurana, N. Nora Bennani, Jonas Paludo, Jose Villasboas Bisneto, Yucai Wang, Stephen M. Ansell, Jennifer L. Peterson, Patrick B. Johnston, Scott C. Lester, Yi Lin
-
Long-term outcomes of allogeneic stem cell transplant in multiple myeloma Blood Cancer J. (IF 12.8) Pub Date : 2023-08-18 Walker M. Schmidt, Nirosha D. Perera, Francis K. Buadi, Suzanne R. Hayman, Shaji K. Kumar, Angela Dispenzieri, David Dingli, Joselle Cook, Martha Q. Lacy, Prashant Kapoor, Nelson Leung, Eli Muchtar, Rahma M. Warsame, Taxiarchis Kourelis, Moritz Binder, Wilson I. Gonsalves, William J. Hogan, Morie A. Gertz
-
Comparison of tisagenlecleucel with conventional treatments for relapsed/refractory diffuse large B-cell lymphomas: a retrospective external comparator study Blood Cancer J. (IF 12.8) Pub Date : 2023-08-18 Sohee Park, Ju Hwan Kim, Songhee Kim, Jisu Kang, Seoyoung Moon, Seok Jin Kim, Ju-Young Shin
-
The oncogenic human B-cell lymphoma MYD88 L265P mutation genocopies activation by phosphorylation at the Toll/interleukin-1 receptor (TIR) domain Blood Cancer J. (IF 12.8) Pub Date : 2023-08-18 Marthe Minderman, Hildo Lantermans, Carmen van der Zwaan, Arie J. Hoogendijk, Maartje van den Biggelaar, Marie José Kersten, Marcel Spaargaren, Steven T. Pals
-
T-cell phenotype including CD57+ T follicular helper cells in the tumor microenvironment correlate with a poor outcome in follicular lymphoma Blood Cancer J. (IF 12.8) Pub Date : 2023-08-18 Zhi-Zhang Yang, Hyo Jin Kim, Hongyan Wu, Xinyi Tang, Yue Yu, Jordan Krull, Daniel P. Larson, Raymond M. Moore, Matthew J. Maurer, Kevin D. Pavelko, Shahrzad Jalali, Joshua C. Pritchett, Rekha Mudappathi, Junwen Wang, Jose C. Villasboas, Patrizia Mondello, Anne J. Novak, Stephen M. Ansell
-
Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusive events Blood Cancer J. (IF 12.8) Pub Date : 2023-08-11 Maymona G. Abdelmagid, Aref Al-Kali, Mark R. Litzow, Kebede H. Begna, William J. Hogan, Mirinal S. Patnaik, Shahrukh K. Hashmi, Michelle A. Elliott, Hassan Alkhateeb, Omer S. Karrar, Farah Fleti, Mohammed H. Elnayir, Candido E. Rivera, Hemant S. Murthy, James M. Foran, Mohamed A. Kharfan-Dabaja, Talha Badar, David S. Viswanatha, Kaaren K. Reichard, Naseema Gangat, Ayalew Tefferi
-
Multiomics of three hematological malignancies in a patient reveal their origin from clonal hematopoietic stem cells Blood Cancer J. (IF 12.8) Pub Date : 2023-08-09 Sylvain Mayeur, Anne Molitor, Laurent Miguet, Lucie Rigolot, Lydie Naegely, Tristan Stemmelen, Sébastien Meyer, Elise Toussaint, Laurent Vallat, Alice Eischen, Marie-Pierre Chenard, Manuela Tavian, Seiamak Bahram, Raphael Carapito, Alina Nicolae
-
Ibrutinib plus fludarabine, cyclophosphamide and rituximab (iFCR) as initial treatment in chronic lymphocytic leukemia/ small lymphocytic leukemia with or without TP53 aberrations: a prospective real-world study in Chinese cohort Blood Cancer J. (IF 12.8) Pub Date : 2023-08-09 Yi Miao, Yeqin Sha, Yi Xia, Shuchao Qin, Rui Jiang, Luomengjia Dai, Hui Shen, Tonglu Qiu, Wei Wu, Jingyan Qiu, Yilian Yang, Chongyang Ding, Yujie Wu, Lei Fan, Wei Xu, Jianyong Li, Huayuan Zhu
-
Coincidence of cutaneous blastic plasmacytoid dendritic cell neoplasm and myelodysplastic syndrome derived from clonal hematopoiesis Blood Cancer J. (IF 12.8) Pub Date : 2023-08-09 Tomohiko Yamada, Nobuhiro Hiramoto, Takuto Mori, Daisuke Yamashita, Yukimasa Tai, Ryusuke Yamamoto, Masashi Nishikubo, Hayato Maruoka, Kana Sakamoto, Kengo Takeuchi, Yasuhito Nannya, Seishi Ogawa, Takayuki Ishikawa
-
Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification Blood Cancer J. (IF 12.8) Pub Date : 2023-08-09 Wan-Hsuan Lee, Ming-Tao Tsai, Cheng-Hong Tsai, Feng-Ming Tien, Min-Yen Lo, Mei-Hsuan Tseng, Yuan-Yeh Kuo, Ming-Chih Liu, Yi-Tsung Yang, Jui-Che Chen, Jih-Luh Tang, Hsun-I Sun, Yi-Kuang Chuang, Liang-In Lin, Wen-Chien Chou, Chien-Chin Lin, Hsin-An Hou, Hwei-Fang Tien
-
Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy Blood Cancer J. (IF 12.8) Pub Date : 2023-08-09 Christopher J. Ferreri, Michelle A. T. Hildebrandt, Hamza Hashmi, Leyla O. Shune, Joseph P. McGuirk, Douglas W. Sborov, Charlotte B. Wagner, M. Hakan Kocoglu, Aaron Rapoport, Shebli Atrash, Peter M. Voorhees, Jack Khouri, Danai Dima, Aimaz Afrough, Gurbakhash Kaur, Larry D. Anderson, Gary Simmons, James A. Davis, Nilesh Kalariya, Lauren C. Peres, Yi Lin, Murali Janakiram, Omar Nadeem, Melissa Alsina
-
Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel Blood Cancer J. (IF 12.8) Pub Date : 2023-08-01 Noopur Raje, Kenneth Anderson, Hermann Einsele, Yvonne Efebera, Francesca Gay, Sarah P. Hammond, Alexander M. Lesokhin, Sagar Lonial, Heinz Ludwig, Philippe Moreau, Krina Patel, Karthik Ramasamy, Maria-Victoria Mateos
-
Survival expectation after thrombosis and overt-myelofibrosis in essential thrombocythemia and prefibrotic myelofibrosis: a multistate model approach Blood Cancer J. (IF 12.8) Pub Date : 2023-07-28 Alessandra Carobbio, Alessandro Maria Vannucchi, Elisa Rumi, Valerio De Stefano, Alessandro Rambaldi, Giuseppe Carli, Maria Luigia Randi, Heinz Gisslinger, Francesco Passamonti, Juergen Thiele, Naseema Gangat, Ayalew Tefferi, Tiziano Barbui
-
In-depth cellular and humoral dynamics of the response to COVID-19 vaccine booster in patients with chronic B-cell neoplasms Blood Cancer J. (IF 12.8) Pub Date : 2023-07-26 Emily Ayers, Glenda Canderan, Michael E. Williams, Behnam Keshavarz, Craig A. Portell, Jeffrey M. Wilson, Judith A. Woodfolk
-
Carfilzomib-induced thrombotic microangiopathy (TMA): an under-recognised spectrum of disease from microangiopathic haemolysis to subclinical TMA. Blood Cancer J. (IF 12.8) Pub Date : 2023-07-26 Royston Ponraj,Adam Bryant,Lindsay Dunlop,Heather Range,Cherry Cobrador,Silvia Ling,Danny Hsu
-
Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma Blood Cancer J. (IF 12.8) Pub Date : 2023-07-25 Carlyn Rose Tan, Andriy Derkach, David Nemirovsky, Amanda Ciardiello, Benjamin Diamond, Malin Hultcrantz, Hani Hassoun, Sham Mailankody, Urvi Shah, Kylee Maclachlan, Dhwani Patel, Oscar B. Lahoud, Heather J. Landau, David J. Chung, Gunjan L. Shah, Michael Scordo, Sergio A. Giralt, Alexander Lesokhin, Saad Z. Usmani, Ola Landgren, Neha Korde
-
Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis Blood Cancer J. (IF 12.8) Pub Date : 2023-07-20 Arleigh McCurdy, Hira Mian, Richard LeBlanc, Victor H. Jimenez-Zepeda, Jiandong Su, Esther Masih-Khan, Alissa Visram, Martha Louzada, Kevin Song, Darrell White, Michael Sebag, Julie Stakiw, Anthony Reiman, Muhammad Aslam, Debra Bergstrom, Rami Kotb, Rayan Kaedbey, Engin Gul, Donna Reece, Christopher P. Venner
-
Nationwide prospective survey of secondary myelofibrosis in Japan: superiority of DIPSS-plus to MYSEC-PM as a survival risk model Blood Cancer J. (IF 12.8) Pub Date : 2023-07-19 Kotaro Shide, Katsuto Takenaka, Akira Kitanaka, Akihiko Numata, Takuro Kameda, Takuji Yamauchi, Atsushi Inagaki, Shohei Mizuno, Akiyoshi Takami, Shinichi Ito, Masao Hagihara, Kensuke Usuki, Takaaki Maekawa, Kazutaka Sunami, Yasunori Ueda, Miyuki Tsutsui, Miki Ando, Norio Komatsu, Keiya Ozawa, Mineo Kurokawa, Shunya Arai, Kinuko Mitani, Koichi Akashi, Kazuya Shimoda
-
Blast phase myeloproliferative neoplasm: contemporary review and 2024 treatment algorithm Blood Cancer J. (IF 12.8) Pub Date : 2023-07-18 Ayalew Tefferi, Hassan Alkhateeb, Naseema Gangat
更新日期：2023-11-27
Copyright © 2014-2023 北京衮雪科技有限公司 All Rights Reserved
京ICP备11026495-2号
京公网安备 11010802027423号
京公网安备 11010802027423号